US 10869863
Multi-arm polymeric targeting anti-cancer conjugate
granted A61KA61K31/4745A61K47/545
Quick answer
US patent 10869863 (Multi-arm polymeric targeting anti-cancer conjugate) held by BrightGene Bio-Medical Technology Co., Ltd. expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BrightGene Bio-Medical Technology Co., Ltd.
- Grant date
- Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4745, A61K47/545, A61K47/58, A61K47/60